Literature DB >> 24587583

Traditional and nontraditional cardiovascular risk factors in comorbid insomnia and sleep apnea.

Faith S Luyster1, Kevin E Kip2, Daniel J Buysse3, Aryan N Aiyer4, Steven E Reis5, Patrick J Strollo6.   

Abstract

OBJECTIVES: Insomnia and sleep apnea frequently co-occur and are independently associated with an increased risk of cardiovascular disease, but little is known about cardiovascular disease risk among individuals with comorbid insomnia and sleep apnea. The current study examined traditional risk factors and a physiologic biomarker of cardiovascular risk in comorbid insomnia and sleep apnea.
DESIGN: Community-based participatory research study. PARTICIPANTS: The sample comprised 795 participants without preexisting cardiovascular disease from the Heart Strategies Concentrating On Risk Evaluation (Heart SCORE) study. MEASUREMENTS AND
RESULTS: Participants were assessed for symptoms of insomnia and sleep apnea risk, as well as for presence of obesity, smoking, a sedentary lifestyle, hypertension, dyslipidemia, and diabetes. Baseline resting brachial artery diameter was measured by B-mode ultrasonography. A total of 138 participants (17.4%) met criteria for insomnia syndrome alone, 179 (22.5%) were at high risk for sleep apnea alone, 95 (11.9%) reported both insomnia syndrome and high sleep apnea risk, and 383 (48.2%) reported having neither insomnia nor sleep apnea symptoms Both high sleep apnea risk alone and comorbid insomnia and high sleep apnea risk groups had greater frequencies of obesity, sedentary lifestyle, hypertension, and three or more traditional cardiovascular risk factors and significantly larger brachial artery diameters than the insomnia alone group and those without insomnia or sleep apnea symptoms. No differences in traditional cardiovascular risk factors or brachial artery diameter were found between the high sleep apnea risk and comorbid groups.
CONCLUSIONS: These findings suggest that sleep apnea is a major contributor to cardiovascular risk and co-occurring insomnia does not appear to add to this risk.

Entities:  

Keywords:  Cardiovascular diseases; hypertension; insomnia; risk factors; sleep apnea

Mesh:

Year:  2014        PMID: 24587583      PMCID: PMC3920326          DOI: 10.5665/sleep.3506

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  68 in total

1.  Oxidative stress in obstructive sleep apnea.

Authors:  Motoo Yamauchi; Hiroshi Nakano; Junko Maekawa; Yukinori Okamoto; Yoshinobu Ohnishi; Takahiro Suzuki; Hiroshi Kimura
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

2.  Prospective study of the association between sleep-disordered breathing and hypertension.

Authors:  P E Peppard; T Young; M Palta; J Skatrud
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

3.  Insomnia in men-a 10-year prospective population based study.

Authors:  C Janson; E Lindberg; T Gislason; A Elmasry; G Boman
Journal:  Sleep       Date:  2001-06-15       Impact factor: 5.849

4.  Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD.

Authors:  B Krakow; D Melendrez; B Pedersen; L Johnston; M Hollifield; A Germain; M Koss; T D Warner; R Schrader
Journal:  Biol Psychiatry       Date:  2001-06-01       Impact factor: 13.382

Review 5.  Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group.

Authors:  Jack D Edinger; Michael H Bonnet; Richard R Bootzin; Karl Doghramji; Cynthia M Dorsey; Colin A Espie; Andrew O Jamieson; W Vaughn McCall; Charles M Morin; Edward J Stepanski
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

6.  Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.

Authors:  A N Vgontzas; E O Bixler; H M Lin; P Prolo; G Mastorakos; A Vela-Bueno; A Kales; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Lipoproteins, cardiovascular disease, and death. The Framingham study.

Authors:  T Gordon; W B Kannel; W P Castelli; T R Dawber
Journal:  Arch Intern Med       Date:  1981-08

8.  Sleep apnea and markers of vascular endothelial function in a large community sample of older adults.

Authors:  F Javier Nieto; David M Herrington; Susan Redline; Emelia J Benjamin; John A Robbins
Journal:  Am J Respir Crit Care Med       Date:  2003-10-09       Impact factor: 21.405

9.  Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS).

Authors:  Simon Smith; Karen Sullivan; Wendy Hopkins; James Douglas
Journal:  Sleep Med       Date:  2004-09       Impact factor: 3.492

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  15 in total

1.  Objective Sleep Duration Is Prospectively Associated With Endothelial Health.

Authors:  Martica H Hall; Suresh Mulukutla; Christopher E Kline; Laura B Samuelsson; Briana J Taylor; Julian F Thayer; Robert T Krafty; Ellen Frank; David J Kupfer
Journal:  Sleep       Date:  2017-01-01       Impact factor: 5.849

2.  Assessment of Snoring and obstructive sleep apnoea in a Nigerian university: Association with cardiovascular risk factors.

Authors:  Adeseye A Akintunde; Afolabi A Salawu; Oladimeji G Opadijo
Journal:  Niger Med J       Date:  2014-11

Review 3.  Sedentary Behavior and Sleep Problems: a Systematic Review and Meta-Analysis.

Authors:  Yan Yang; Jong Cheol Shin; Dongying Li; Ruopeng An
Journal:  Int J Behav Med       Date:  2017-08

Review 4.  Shift Work and Obesity Risk-Are There Sex Differences?

Authors:  Kevin L Smith; Alexandria B Danyluk; Sanah S Munir; Naima Covassin
Journal:  Curr Diab Rep       Date:  2022-06-23       Impact factor: 5.430

5.  All-Cause Mortality in People with Co-Occurring Insomnia Symptoms and Sleep Apnea: Analysis of the Wisconsin Sleep Cohort.

Authors:  Bastien Lechat; Kelly A Loffler; Douglas M Wallace; Amy Reynolds; Sarah L Appleton; Hannah Scott; Andrew Vakulin; Nicole Lovato; Robert Adams; Danny J Eckert; Peter G Catcheside; Alexander Sweetman
Journal:  Nat Sci Sleep       Date:  2022-10-13

6.  Comorbid Insomnia With Obstructive Sleep Apnea: Clinical Characteristics and Risk Factors.

Authors:  Yong Won Cho; Keun Tae Kim; Hye-Jin Moon; Valeriy R Korostyshevskiy; Gholam K Motamedi; Kwang Ik Yang
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

7.  Sleep Disturbance, Diabetes, and Cardiovascular Disease in Postmenopausal Veteran Women.

Authors:  Michelle B Rissling; Kristen E Gray; Christi S Ulmer; Jennifer L Martin; Oleg Zaslavsky; Shelly L Gray; Lauren Hale; Jamie M Zeitzer; Michelle Naughton; Nancy F Woods; Andrea LaCroix; Patrick S Calhoun; Marcia Stefanick; Julie C Weitlauf
Journal:  Gerontologist       Date:  2016-02

8.  QT Interval Variability Index and QT Interval Duration in Different Sleep Stages: Analysis of Polysomnographic Recordings in Nonapneic Male Patients.

Authors:  Moonika Viigimae; Deniss Karai; Peeter Pirn; Kristjan Pilt; Kalju Meigas; Jyri Kaik
Journal:  Biomed Res Int       Date:  2015-11-29       Impact factor: 3.411

9.  Metabolic outcomes in adults with type 2 diabetes and sleep disorders.

Authors:  Christopher C Imes; Zhadyra Bizhanova; Susan M Sereika; Mary T Korytkowski; Charles W Atwood; Lora E Burke; Jacob Kariuki; Jonna L Morris; Robert Stansbury; Patrick J Strollo; Eileen R Chasens
Journal:  Sleep Breath       Date:  2021-06-09       Impact factor: 2.816

10.  Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi-Ethnic Study of Atherosclerosis.

Authors:  Glaucylara Reis Geovanini; Rui Wang; Jia Weng; Nancy S Jenny; Steven Shea; Matthew Allison; Peter Libby; Susan Redline
Journal:  Ann Am Thorac Soc       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.